The Food and Drug Administration (FDA) has recently granted approval for LYFGENIA™ (lovotibeglogene autotemcel), a groundbreaking treatment for sickle cell...
The Food and Drug Administration (FDA) has recently approved LYFGENIA™, a groundbreaking treatment developed by Bluebird bio, for patients aged...
FDA Approves Two Gene Therapies for Sickle Cell, Introducing New Paolo Macchiarini Series, and Exploring Fujifilm’s Niche The field of...
Experts at the American Society of Hematology (ASH) are cautiously optimistic about the recent historic approval of gene therapies for...
Can both sickle cell gene therapies succeed in the U.S. market? Sickle cell disease (SCD) is a genetic disorder that...
Challenges in Accessing Expensive Gene Therapies for Sickle Cell Disease Sickle Cell Disease (SCD) is a genetic disorder that affects...
Bluebird Bio, a biotechnology company, recently received approval from the U.S. Food and Drug Administration (FDA) for its gene therapy...
FDA Grants Approval for Groundbreaking Sickle Cell Gene Therapies, Casgevy and Lyfgenia – Drugs.com MedNews The Food and Drug Administration...
Xenon’s $345 Million Public Offering, EyePoint Pharmaceuticals’ Successful Trial, and Promising Gene Therapy for Liver Cancer Reduction In recent news,...
Xenon’s Successful $345 Million Public Offering, EyePoint Pharmaceuticals’ Promising Trial Results, and Discovery of Liver Cancer Reduction through Gene Therapy...
The Importance of an ‘Innovation-First’ Mindset for the Future of the Advanced Therapies Sector The advanced therapies sector is rapidly...
The California Institute for Regenerative Medicine (CIRM) has recently announced the allocation of $17.5 million for clinical-stage research, with a...
Exploring the Compatibility of SENS with the Hallmarks of Aging: A Comprehensive Analysis by the SENS Research Foundation (Part One)...
Neurogene Administers Therapy for Rett Syndrome to Two Pediatric Patients in Clinical Trial Rett Syndrome is a rare genetic disorder...
Exploring Funding and Research Areas in Regenerative Medicine, Oral Delivery, Therapeutics, DNA Platform for Rheumatoid Arthritis, and Cancer Therapy In...
